|
1
|
Wang C, Dong C and Xiong S: IL-33 enhances
macrophage M2 polarization and protects mice from CVB3-induced
viral myocarditis. J Mol Cell Cardiol. 103:22–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nguyen VK, Klawonn F, Mikolajczyk R and
Hernandez-Vargas EA: Analysis of practical identifiability of a
viral infection model. PLoS One. 11:e01675682016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rienks M, Papageorgiou A, Wouters K,
Verhesen W, Leeuwen RV, Carai P, Summer G, Westermann D and Heymans
S: A novel 72-kDa leukocyte-derived osteoglycin enhances the
activation of toll-like receptor 4 and exacerbates cardiac
inflammation during viral myocarditis. Cell Mol Life Sci.
74:1511–1525. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yue-Chun L, Guang-Yi C, Li-Sha G, Chao X,
Xinqiao T, Cong L, Xiao-Ya D and Xiangjun Y: The protective effects
of ivabradine in preventing progression from viral myocarditis to
dilated cardiomyopathy. Front Pharmacol. 7:4082016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Márquez-González H, López-Gallegos D,
González-Espinosa AM, Zamudio-López JO and Yáñez-Gutiérrez L:
Effect of immune therapy in the prognosis of viral myocarditis in
pediatric patients. Rev Med Inst Mex Seguro Soc. 54 Suppl
3:S296–S301. 2016.PubMed/NCBI
|
|
6
|
Yu M, Long Q, Li HH, Liang W, Liao YH,
Yuan J and Cheng X: IL-9 inhibits viral replication in
coxsackievirus B3-induced myocarditis. Front Immunol. 7:4092016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
An B, Liu X, Li G and Yuan H:
Interleukin-37 ameliorates coxsackievirus B3-induced viral
myocarditis by modulating the Th17/regulatory T cell immune
response. J Cardiovasc Pharmacol. 69:305–313. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alhouayek M and Muccioli GG: COX-2-derived
endocannabinoid metabolites as novel inflammatory mediators. Trends
Pharmacol Sci. 35:284–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hao Y, Gu X, Zhao Y, Greene S, Sha W,
Smoot DT, Califano J, Wu TC and Pang X: Enforced expression of
miR-101 inhibits prostate cancer cell growth by modulating the
COX-2 pathway in vivo. Cancer Prev Res (Phila). 4:1073–1083. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu T: Diagnostic criteria for viral
myocarditis (Revised Draft). Chin J Prac Pediat. 5:3152000.(In
Chinese).
|
|
11
|
Casadonte JR, Mazwi ML, Gambetta KE, Palac
HL, McBride ME, Eltayeb OM, Monge MC, Backer CL and Costello JM:
Risk factors for cardiac arrest or mechanical circulatory support
in children with fulminant myocarditis. Pediatr Cardiol.
38:128–134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Simpson KE, Storch GA, Lee CK, Ward KE,
Danon S, Simon CM, Delaney JW, Tong A and Canter CE: High frequency
of detection by pcr of viral nucleic acid in the blood of infants
presenting with clinical myocarditis. Pediatr Cardiol. 37:399–404.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tse G, Yeo JM, Chan YW, Lai ET and Yan BP:
What is the arrhythmic substrate in viral myocarditis? Insights
from clinical and animal studies. Front Physiol. 7:3082016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grodums EI and Dempster G: The
pathogenesis of Coxsackie group B viruses in experimental
infection. Can J Microbiol. 8:105–113. 1962. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Webb SR, Loria RM, Madge GE and Kibrick S:
Susceptibility of mice to group B coxsackie virus is influenced by
the diabetic gene. J Exp Med. 143:1239–1248. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bardooli F, McAlindon E, Littlejohns B,
Suleiman MS, Chiara BD and Baumbach A: TCT-184 Early changes in
circulating miRNA 133a are indicative of cardiac remodelling after
3 months in patients presenting with acute ST elevation myocardial
infarction. J Am Coll Cardiol. 68:B75–B76. 2016. View Article : Google Scholar
|
|
17
|
Wang Y, Ouyang M, Wang Q and Jian Z:
MicroRNA-142-3p inhibits hypoxia/reoxygenationinduced apoptosis and
fibrosis of cardiomyocytes by targeting high mobility group box 1.
Int J Mol Med. 38:1377–1386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh GB, Raut SK, Khanna S, Kumar A,
Sharma S, Prasad R and Khullar M: MicroRNA-200c modulates DUSP-1
expression in diabetes-induced cardiac hypertrophy. Mol Cell
Biochem. 424:1–11. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu D, Wang D, Xu Z, Gao J, Liu M, Liu Y,
Jiang M and Zheng D: Dysregulated expression of miR-101b and
miR-26b lead to age-associated increase in LPS-induced COX-2
expression in murine macrophage. Age (Dordr). 37:972015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang Y, Zhao Q, Fan L, Zhang Z, Tan B,
Liu Y and Li Y: Down-regulation of MicroRNA-381 promotes cell
proliferation and invasion in colon cancer through up-regulation of
LRH-1. Biomed Pharmacother. 75:137–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang HQ, Wang RJ, Diao CF, Li JW, Su JL
and Zhang S: The PTTG1-targeting miRNAs miR-329, miR-300, miR-381
and miR-655 inhibit pituitary tumor cell tumorigenesis and are
involved in a p53/PTTG1 regulation feedback loop. Oncotarget.
6:29413–29427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu Y, Ohms SJ, Li Z, Wang Q, Gong G, Hu Y,
Mao Z, Shannon MF and Fan JY: Changes in the expression of miR-381
and miR-495 are inversely associated with the expression of the
MDR1 gene and development of multi-drug resistance. PLoS One.
8:e820622013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen B, Duan L, Yin G, Tan J and Jiang X:
Simultaneously expressed miR-424 and miR-381 synergistically
suppress the proliferation and survival of renal cancer cells-Cdc2
activity is up-regulated by targeting WEE1. Clinics (Sao Paulo).
68:825–833. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rothschild SI, Tschan MP, Jaggi R, Fey MF,
Gugger M and Gautschi O: MicroRNA-381 represses ID1 and is
deregulated in lung adenocarcinoma. J Thorac Oncol. 7:1069–1077.
2012. View Article : Google Scholar : PubMed/NCBI
|
